A Randomized, Controlled, Phase 1 Study of the Safety and Immunogenicity of the AMA1-C1/Alhydrogel(®) + CPG 7909 Vaccine for Plasmodium falciparum Malaria, in Semi-immune Malian Adults

A double blind, randomized, controlled Phase 1 clinical trial was conducted to assess the safety and immunogenicity in malaria exposed adults of the Plasmodium falciparum blood stage vaccine candidate Apical Membrane Antigen 1- Combination 1 (AMA1-C1)/Alhydrogel(®) with and without the novel adjuvan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sagara, Issaka, Ellis, Ruth D., Dicko, Alassane, Niambele, Mohamed B., Kamate, Beh, Guindo, Ousmane, Sissoko, Mahamadou S., Fay, Michael P., Guindo, Merepen A., Kante, Ousmane, Saye, Renion, Miura, Kazutoyo, Long, Carole, Mullen, Gregory E.D., Pierce, Mark, Martin, Laura B., Rausch, Kelly, Dolo, Amagana, Diallo, Dapa A., Miller, Louis H, Doumbo, Ogobara K
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2808270/
https://ncbi.nlm.nih.gov/pubmed/19874925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.10.087
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados